Indonesia's recent market trends indicate a resilient, cautiously optimistic economic landscape. Its upcoming election is one to watch for investors and businesses.
Decision-making, Factionalism, and Government Relations in Japan January 2024 This article is part of Sandpiper’s Public Affairs Tracker content series on government relations in Asia-Pacific. Here, […]
Our top tips for communicators, marketeers and policymakers looking for their organisation and leadership to shape the debate and to have an impact at Davos 2024.
2024 is bringing a new set of changes, challenges, and opportunities to Asia Pacific’s healthcare sector. Shifting demographics, social changes, and new technologies such as cell and gene therapies, bio-inductive implants, and AI-assisted discovery are expected to reshape the industry.
The challenges faced by globalisation are evolving in real time. For those concentrating on Asia-Pacific, here are the top three worth-noting development.
Given China's size, economic growth and influence, it’s imperative for financial firms to have a customised PR strategy for the Chinese market to be successful.
Under China's new medical reform, the government has become the largest purchaser of medicine. For pharmaceutical enterprises, favourable policies are the key to market access.
Despite domestic and external uncertainties, during the "Two Sessions", China announced a series of policy backstops to stabilise growth, generate confidence...
Amid ongoing global economic and geopolitical disruptions, understanding the political and regulatory landscape has never been more critical to ensuring business success in China